Top compounds associated with response to LRFN2


Feature Type Standardized
Nominal ANOVA
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA YM-155 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.033 0.3
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA Cyclopamine GDSC1000 pan-cancer AAC 0.055 0.3
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.3
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.034 0.3
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.036 0.3
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.051 0.3
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.034 0.3
Download CSV